News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
57,406 Results
Type
Article (6284)
Company Profile (13)
Press Release (51109)
Section
Business (14757)
Career Advice (50)
Deals (2256)
Drug Delivery (11)
Drug Development (12093)
Employer Resources (13)
FDA (1913)
Job Trends (2234)
News (30447)
Policy (4999)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
2026 Genetown Elite (1)
Academia (361)
Adcomms (3)
Allergies (7)
Alliances (4979)
ALS (1)
Alzheimer's disease (124)
Antibody-drug conjugate (ADC) (6)
Approvals (1936)
Artificial intelligence (10)
Autoimmune disease (3)
Automation (1)
Bankruptcy (28)
Best Places to Work (2085)
BIOSECURE Act (2)
Biosimilars (9)
Biotechnology (8)
Bladder cancer (9)
Brain cancer (2)
Breast cancer (18)
Cancer (180)
Cardiovascular disease (4)
Career advice (47)
CAR-T (19)
Cell therapy (45)
Cervical cancer (3)
Clinical research (8525)
Collaboration (73)
Compensation (7)
Complete response letters (1)
COVID-19 (2028)
CRISPR (2)
C-suite (20)
Cystic fibrosis (9)
Data (197)
Depression (1)
Diabetes (8)
Diagnostics (370)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (9)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (2)
Earnings (4725)
Editorial (7)
Employer branding (1)
Employer resources (12)
Events (6720)
Executive appointments (41)
FDA (2061)
Featured Employer (3)
Funding (52)
Gene editing (9)
Generative AI (2)
Gene therapy (26)
GLP-1 (68)
Government (1801)
Grass and pollen (1)
Guidances (5)
Healthcare (1721)
Immunology and inflammation (13)
Indications (1)
Infectious disease (2119)
Inflammatory bowel disease (17)
Inflation Reduction Act (1)
Influenza (38)
Intellectual property (5)
Interviews (4)
IPO (996)
IRA (5)
Job creations (289)
Job search strategy (47)
Labor market (1)
Layoffs (67)
Legal (479)
Liver cancer (2)
Lung cancer (13)
Lymphoma (17)
Management (7)
Manufacturing (40)
MASH (1)
Medical device (362)
Medtech (362)
Mergers & acquisitions (1286)
Metabolic disorders (27)
Multiple sclerosis (12)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (152)
NextGen: Class of 2025 (334)
Non-profit (331)
Northern California (119)
Now hiring (4)
Obesity (13)
Opinion (29)
Ovarian cancer (15)
Pain (3)
Pancreatic cancer (4)
Parkinson's disease (5)
Partnered (1)
Patents (21)
Patient recruitment (1)
Peanut (6)
People (4273)
Pharmaceutical (5)
Phase I (3048)
Phase II (3553)
Phase III (3206)
Pipeline (89)
Podcasts (13)
Policy (25)
Postmarket research (386)
Preclinical (1172)
Press Release (19)
Prostate cancer (6)
Psychedelics (4)
Radiopharmaceuticals (11)
Rare diseases (30)
Real estate (484)
Recruiting (5)
Regulatory (3188)
Reports (11)
Research institute (378)
Resumes & cover letters (2)
RNA editing (1)
RSV (44)
Schizophrenia (1)
Series A (5)
Series B (3)
Service/supplier (1)
Sickle cell disease (4)
Southern California (117)
Sponsored (4)
Startups (270)
Supply chain (9)
The Weekly (13)
United States (1651)
Vaccines (729)
Venture capitalists (3)
Webinars (1)
Weight loss (16)
Date
Today (19)
Last 7 days (64)
Last 30 days (253)
Last 365 days (3098)
2025 (473)
2024 (3160)
2023 (3769)
2022 (6885)
2021 (7831)
2020 (6289)
2019 (2781)
2018 (2132)
2017 (2125)
2016 (2110)
2015 (2571)
2014 (1995)
2013 (1619)
2012 (1814)
2011 (1951)
2010 (1810)
Location
Africa (161)
Alabama (16)
Alaska (1)
Arizona (2)
Asia (3917)
Australia (618)
California (284)
Canada (136)
China (29)
Colorado (10)
Connecticut (18)
Delaware (12)
Europe (9282)
Florida (36)
Georgia (34)
Idaho (1)
Illinois (16)
India (5)
Indiana (23)
Japan (16)
Kansas (8)
Kentucky (2)
Maine (1)
Maryland (268)
Massachusetts (219)
Michigan (7)
Minnesota (6)
Missouri (4)
Montana (8)
Nebraska (2)
Nevada (1)
New Hampshire (1)
New Jersey (279)
New Mexico (2)
New York (161)
North Carolina (48)
North Dakota (6)
Northern California (119)
Ohio (9)
Pennsylvania (121)
Puerto Rico (1)
Rhode Island (5)
South America (97)
Southern California (117)
Tennessee (1)
Texas (30)
Utah (4)
Virginia (8)
Washington D.C. (3)
Washington State (36)
Wisconsin (1)
57,406 Results for "alopexx vaccine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Alopexx Announces Collaboration with Bharat Biotech for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV0328
September 10, 2024
·
6 min read
Press Releases
Alopexx Announces Investment from Biotech Consortia, Inc.
September 6, 2024
·
4 min read
Genetown
Alopexx Announces Presentation at IDWeek 2023
Alopexx, Inc. is scheduled to present pre-clinical data at IDWeek 2023’s Microbial Pathogenesis of Alzheimer’s Disease symposium being held October 11-15, 2023 in Boston, MA.
October 11, 2023
·
3 min read
Genetown
Alopexx to Present Data on F598, a Novel, Broad-Spectrum Immunotherapeutic at IDWeek 2023
Alopexx, Inc. today announced that Daniel Vlock, MD, Co-Founder, Chief Executive Officer and Chairman of the Board of Alopexx, is scheduled to present at IDWeek’s 2023’s New Antimicrobials in the Pipeline symposium being held October 11-15, 2023 in Boston, MA.
October 12, 2023
·
3 min read
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC advisory committee meetings.
March 5, 2025
·
2 min read
·
Tristan Manalac
Vaccines
CDC Vaccine Advisory Board Meeting Postponed Days After RFK Jr. Confirmation
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human Services, despite controversy regarding his anti-vaccine history.
February 21, 2025
·
2 min read
·
Tristan Manalac
Government
RFK Jr. Again Faces Scrutiny Over Vaccines on Day 2 of Confirmation Hearing
Senators on the Health, Education, Labor and Pensions committee were critical of Kennedy’s long history as an anti-vaccine campaigner.
January 31, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr. comes as the U.S. records its first death from measles since 2015.
February 27, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Sanofi Hit With $250M Impairment After Scrapping J&J-Partnered
E. coli
Vaccine
Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent invasive
E. coli
disease versus placebo.
February 13, 2025
·
2 min read
·
Tristan Manalac
1 of 5,741
Next
